Trastuzumab and anthracyclines associated with cardiotoxicity

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2016年 / 1600卷 / 1期
关键词：
D O I：
10.1007/s40278-016-17099-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：14 / 14
相关论文
共 50 条
  • [21] Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
    Sawaya, Heloisa
    Sebag, Igal A.
    Plana, Juan Carlos
    Januzzi, James L.
    Ky, Bonnie
    Tan, Timothy C.
    Cohen, Victor
    Banchs, Jose
    Carver, Joseph R.
    Wiegers, Susan E.
    Martin, Randolph P.
    Picard, Michael H.
    Gerszten, Robert E.
    Halpern, Elkan F.
    Passeri, Jonathan
    Kuter, Irene
    Scherrer-Crosbie, Marielle
    CIRCULATION-CARDIOVASCULAR IMAGING, 2012, 5 (05) : 596 - 603
  • [22] Preventive strategies for anthracyclines and trastuzumab induced cardiotoxicity: a systematic review and meta-analysis
    Costa Oliveira, C. C. Catia
    Campos, R.
    Braga, C.
    Pereira, V. H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 278 - 278
  • [23] Cardiotoxicity associated with paclitaxel trastuzumab combination therapy
    Jerian, S
    Keegan, P
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) : 1647 - 1648
  • [24] TRASTUZUMAB INDUCED CARDIOTOXICITY: WITHOUT PRIOR ANTHRACYCLINES, DECREASE IN LEFT VENTRICULAR EJECTION FRACTION IS NEGLIGIBLE
    Guglin, Maya E.
    Tamura, Roy
    Krischer, Jeffrey
    Munster, Pamela
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 672 - 672
  • [25] Echocardiographic and biological prospective assessment of cardiotoxicity in patients with breast cancer receiving taxanes, anthracyclines and/or trastuzumab
    Peset Cubero, A. M.
    Cortell Fuster, A.
    Rodriguez Navarro, C.
    Solloso Martinez, A.
    Facila Rubio, L.
    Montagud Balaguer, V.
    Soler Lopez, J.
    Olmos Anton, S.
    Munarriz Ferrandis, J.
    Martinez De Duenas, E.
    EUROPEAN HEART JOURNAL, 2013, 34 : 211 - 212
  • [26] Cardiotoxicity associated with Herceptin (trastuzumab) therapy: A potential mechanism
    Zuppinger, C
    Sawyer, DB
    Miller, T
    Eppenberger, HM
    Suter, TM
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S96 - S96
  • [27] Cardiotoxicity associated with the use of trastuzumab in breast cancer patients
    Perik, Patrick J.
    de Korte, Maarten Alexander
    van Veldhuisen, Dirk J.
    Gietema, Jourik A.
    Sleijfer, Dirk T.
    de Vries, Elisabeth G. E.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (12) : 1763 - 1771
  • [28] Cardiotoxicity associated with paclitaxel trastuzumab combination therapy - Reply
    Perez, EA
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) : 1648 - 1648
  • [29] Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis
    Guenancia, Charles
    Lefebvre, Annick
    Cardinale, Daniela
    Yu, Anthony F.
    Ladoire, Sylvain
    Ghiringhelli, Francois
    Zeller, Marianne
    Rochette, Luc
    Cottin, Yves
    Vergely, Catherine
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26) : 3157 - +
  • [30] Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis
    Mary Obasi
    Arielle Abovich
    Jacqueline B. Vo
    Yawen Gao
    Stefania I. Papatheodorou
    Anju Nohria
    Aarti Asnani
    Ann H. Partridge
    Cancer Causes & Control, 2021, 32 : 1395 - 1405
12345